[HTML][HTML] Curcumin against prostate cancer: current evidence

D Termini, DJ Den Hartogh, A Jaglanian, E Tsiani - Biomolecules, 2020 - mdpi.com
Cancer is a condition characterized by remarkably enhanced rates of cell proliferation
paired with evasion of cell death. These deregulated cellular processes take place following …

[HTML][HTML] Prostate cancer: current treatment and prevention strategies

F Chen, X Zhao - Iranian Red Crescent Medical Journal, 2013 - ncbi.nlm.nih.gov
Prostate cancer is one of the life threatening disorders of male. Although, over the last two
decades, a high rate of overdiagnosis, and overtreatment has lowered the incidence rate of …

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease

DJ Laderach, LD Gentilini, L Giribaldi, VC Delgado… - Cancer research, 2013 - AACR
Galectins, a family of glycan-binding proteins, influence tumor progression by modulating
interactions between tumor, endothelial, stromal, and immune cells. Despite considerable …

CYP17A1 inhibitors in castration-resistant prostate cancer

L Gomez, JR Kovac, DJ Lamb - Steroids, 2015 - Elsevier
The majority of prostate cancer (PCa) cases are diagnosed as a localized disease. Definitive
treatment, active surveillance or watchful waiting are employed as therapeutic paradigms …

[HTML][HTML] ERK5 signalling in prostate cancer promotes an invasive phenotype

AK Ramsay, SRC McCracken, M Soofi… - British journal of …, 2011 - nature.com
Background: Aberrant mitogen/extracellular signal-regulated kinase 5 (MEK5)–extracellular
signal-regulated protein kinase 5 (ERK5)-mediated signalling has been implicated in a …

[HTML][HTML] Anticancer activity of a sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast and prostate cancer cells in vitro

NS Yaacob, N Hamzah… - … and alternative medicine, 2010 - Springer
Abstract Background The leaves of Strobilanthes crispus (S. crispus) which is native to the
regions of Madagascar to the Malay Archipelago, are used in folk medicine for their …

Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer

M Ferrando, G Gueron, B Elguero, J Giudice, A Salles… - Angiogenesis, 2011 - Springer
Prostate cancer (PCa) is the second leading cause of cancer-associated death in men. Once
a tumor is established it may attain further characteristics via mutations or hypoxia, which …

[HTML][HTML] Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of …

S Sharma, K Cwiklinski, DE Sykes, SD Mahajan… - Cancers, 2022 - mdpi.com
Simple Summary Prostate specific membrane antigen and galectins are proteins expressed
on cell surface and their expression is associated with cancer growth and spread. The goal …

Evaluation of Cisplatin in Combination with β‐Elemene as a Regimen for Prostate Cancer Chemotherapy

QQ Li, G Wang, E Reed, L Huang… - Basic & clinical …, 2010 - Wiley Online Library
Cisplatin is one of the most potent chemotherapeutic agents for the treatment of many types
of solid tumours. Nevertheless, it is not the first‐line drug for prostate cancer chemotherapy …

Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?

D Verzella, M Fischietti, D Capece… - Current drug …, 2016 - ingentaconnect.com
Rel/NF-ΚB transcription factors are key regulators of genes implicated in inflammatory and
immune activation, cell growth and protection from apoptosis. Constitutive activation of NF …